WO2003030821A3 - Albumin fusion proteins - Google Patents
Albumin fusion proteins Download PDFInfo
- Publication number
- WO2003030821A3 WO2003030821A3 PCT/US2002/031794 US0231794W WO03030821A3 WO 2003030821 A3 WO2003030821 A3 WO 2003030821A3 US 0231794 W US0231794 W US 0231794W WO 03030821 A3 WO03030821 A3 WO 03030821A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fusion proteins
- albumin fusion
- nucleic acids
- vectors
- host cells
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002332041A AU2002332041A1 (en) | 2001-10-05 | 2002-10-04 | Albumin fusion proteins |
US10/816,042 US20050037022A1 (en) | 2001-10-05 | 2004-04-02 | Albumin fusion proteins |
US11/341,748 US20060166329A1 (en) | 2001-10-05 | 2006-01-30 | Albumin fusion proteins |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32728101P | 2001-10-05 | 2001-10-05 | |
US60/327,281 | 2001-10-05 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/816,042 Continuation US20050037022A1 (en) | 2001-10-05 | 2004-04-02 | Albumin fusion proteins |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003030821A2 WO2003030821A2 (en) | 2003-04-17 |
WO2003030821A3 true WO2003030821A3 (en) | 2003-12-11 |
Family
ID=23275906
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/031794 WO2003030821A2 (en) | 2001-10-05 | 2002-10-04 | Albumin fusion proteins |
Country Status (3)
Country | Link |
---|---|
US (2) | US20050037022A1 (en) |
AU (1) | AU2002332041A1 (en) |
WO (1) | WO2003030821A2 (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2686899B1 (en) * | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | NOVEL BIOLOGICALLY ACTIVE POLYPEPTIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
GB9526733D0 (en) | 1995-12-30 | 1996-02-28 | Delta Biotechnology Ltd | Fusion proteins |
EP1832599A3 (en) * | 2000-04-12 | 2007-11-21 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US20060084794A1 (en) * | 2001-04-12 | 2006-04-20 | Human Genome Sciences, Inc. | Albumin fusion proteins |
AU2002332041A1 (en) * | 2001-10-05 | 2003-04-22 | Human Genome Sciences, Inc. | Albumin fusion proteins |
DK1463751T3 (en) | 2001-12-21 | 2013-08-26 | Human Genome Sciences Inc | Albumin Fusion Proteins. |
AU2002364587A1 (en) | 2001-12-21 | 2003-07-30 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US7220407B2 (en) | 2003-10-27 | 2007-05-22 | Amgen Inc. | G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction |
AU2004295171A1 (en) * | 2003-12-03 | 2005-06-16 | Novozymes Biopharma Dk A/S | Interleukin-11 fusion proteins |
DK1729795T3 (en) * | 2004-02-09 | 2016-04-11 | Human Genome Sciences Inc | Albumin fusion proteins |
CA2586365A1 (en) | 2004-11-05 | 2006-05-26 | Northwestern University | Use of scf and g-csf in the treatment of cerebral ischemia and neurological disorders |
EP1816201A1 (en) | 2006-02-06 | 2007-08-08 | CSL Behring GmbH | Modified coagulation factor VIIa with extended half-life |
JP5061194B2 (en) * | 2006-10-27 | 2012-10-31 | イノヴァ ダイアグノスティクス インコーポレイテッド | Methods and assays for detecting GP73-specific autoantibodies |
US9272034B2 (en) * | 2007-10-04 | 2016-03-01 | The Regents Of The University Of California | Treatment of conditions related to shock |
EP2344913B1 (en) * | 2008-10-02 | 2015-02-18 | Ramot at Tel-Aviv University Ltd. | Method and system for emitting light |
US9295715B2 (en) | 2010-10-02 | 2016-03-29 | The Regents Of The University Of California | Minimizing intestinal dysfunction |
WO2013106485A2 (en) | 2012-01-09 | 2013-07-18 | The Scripps Research Institute | Ultralong complementarity determining regions and uses thereof |
JP2015509091A (en) | 2012-01-09 | 2015-03-26 | ザ スクリプス リサーチ インスティテュート | Humanized antibody |
WO2014110368A1 (en) * | 2013-01-11 | 2014-07-17 | The California Institute For Biomedical Research | Bovine fusion antibodies |
WO2015010100A2 (en) | 2013-07-18 | 2015-01-22 | Fabrus, Inc. | Humanized antibodies with ultralong complementarity determining regions |
US10767164B2 (en) | 2017-03-30 | 2020-09-08 | The Research Foundation For The State University Of New York | Microenvironments for self-assembly of islet organoids from stem cells differentiation |
CA3100007A1 (en) | 2018-05-14 | 2019-11-21 | Werewolf Therapeutics, Inc. | Activatable interleukin-2 polypeptides and methods of use thereof |
SG11202011309SA (en) | 2018-05-14 | 2020-12-30 | Werewolf Therapeutics Inc | Activatable interleukin 12 polypeptides and methods of use thereof |
CN111418580A (en) * | 2020-05-25 | 2020-07-17 | 山东万能干细胞生物技术有限公司 | Stem cell cryopreservation solution and cryopreservation method |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5216131A (en) * | 1989-02-23 | 1993-06-01 | Genentech, Inc. | Lymphocyte homing receptors |
US6121231A (en) * | 1996-12-06 | 2000-09-19 | Institut Pasteur | Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuromal and neural injury |
US6210901B1 (en) * | 1994-01-31 | 2001-04-03 | Roche Diagnostics Gmbh | Specific binding substances for antibodies and their use for immunoassays or vaccines |
US20010056075A1 (en) * | 1999-07-19 | 2001-12-27 | Jeno Gyuris | Chimeric polypeptides of serum albumin and uses related thereto |
US6548653B1 (en) * | 1998-06-15 | 2003-04-15 | Genzyme Transgenics Corporation | Erythropoietin analog-human serum albumin fusion |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2449885C3 (en) * | 1974-10-21 | 1980-04-30 | Biotest-Serum-Institut Gmbh, 6000 Frankfurt | Process for the production of chemically modified, long-life hemoglobin preparations as well as the modified hemoglobin preparation produced by this process |
US4959314A (en) * | 1984-11-09 | 1990-09-25 | Cetus Corporation | Cysteine-depleted muteins of biologically active proteins |
US4970300A (en) * | 1985-02-01 | 1990-11-13 | New York University | Modified factor VIII |
GB8504099D0 (en) * | 1985-02-18 | 1985-03-20 | Wellcome Found | Physiologically active substances |
FR2579224B1 (en) * | 1985-03-25 | 1987-05-22 | Genetica | PROCESS FOR THE MICROBIOLOGICAL PREPARATION OF HUMAN SERUM-ALBUMIN |
US4751180A (en) * | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
US5641663A (en) * | 1985-11-06 | 1997-06-24 | Cangene Corporation | Expression system for the secretion of bioactive human granulocyte macrophage colony stimulating factor (GM-CSF) and other heterologous proteins from steptomyces |
FR2594846B1 (en) * | 1986-02-21 | 1989-10-20 | Genetica | PROCESS FOR THE PREPARATION OF MATURE HUMAN ALBUMIN SERUM |
US4765980A (en) * | 1986-04-28 | 1988-08-23 | International Minerals & Chemical Corp. | Stabilized porcine growth hormone |
US4801575A (en) * | 1986-07-30 | 1989-01-31 | The Regents Of The University Of California | Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
US5336603A (en) * | 1987-10-02 | 1994-08-09 | Genentech, Inc. | CD4 adheson variants |
GB8725529D0 (en) * | 1987-10-30 | 1987-12-02 | Delta Biotechnology Ltd | Polypeptides |
JP3092811B2 (en) * | 1988-07-23 | 2000-09-25 | デルタ バイオテクノロジー リミテッド | Peptide and DNA sequences |
US5116964A (en) * | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
US5705363A (en) * | 1989-03-02 | 1998-01-06 | The Women's Research Institute | Recombinant production of human interferon τ polypeptides and nucleic acids |
US5766883A (en) * | 1989-04-29 | 1998-06-16 | Delta Biotechnology Limited | Polypeptides |
EP0429586B1 (en) * | 1989-06-09 | 1995-08-02 | Gropep Pty. Ltd. | Growth hormone fusion proteins |
FR2650598B1 (en) * | 1989-08-03 | 1994-06-03 | Rhone Poulenc Sante | DERIVATIVES OF ALBUMIN WITH THERAPEUTIC FUNCTION |
US5073627A (en) * | 1989-08-22 | 1991-12-17 | Immunex Corporation | Fusion proteins comprising GM-CSF and IL-3 |
US5116944A (en) * | 1989-12-29 | 1992-05-26 | Neorx Corporation | Conjugates having improved characteristics for in vivo administration |
US5272070A (en) * | 1991-03-08 | 1993-12-21 | Board Of Regents, The University Of Texas System | Method for the preparation of cell lines producing Man3 GlcNac 2 asparagine-linked gylcans and cell lines produced thereby |
US5646012A (en) * | 1991-04-30 | 1997-07-08 | Rhone-Poulenc Rorer S.A. | Yeast promoter and use thereof |
US5844095A (en) * | 1991-06-27 | 1998-12-01 | Bristol-Myers Squibb Company | CTLA4 Ig fusion proteins |
US5851795A (en) * | 1991-06-27 | 1998-12-22 | Bristol-Myers Squibb Company | Soluble CTLA4 molecules and uses thereof |
US5223408A (en) * | 1991-07-11 | 1993-06-29 | Genentech, Inc. | Method for making variant secreted proteins with altered properties |
WO1993008842A1 (en) * | 1991-11-08 | 1993-05-13 | Somatogen, Inc. | Hemoglobins as drug delivery agents |
FR2686620B1 (en) * | 1992-01-27 | 1995-06-23 | Rhone Poulenc Rorer Sa | HUMAN SERUM-ALBUMIN, PREPARATION AND USE. |
FR2686899B1 (en) * | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | NOVEL BIOLOGICALLY ACTIVE POLYPEPTIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
FR2686900B1 (en) * | 1992-01-31 | 1995-07-21 | Rhone Poulenc Rorer Sa | NOVEL POLYPEPTIDES HAVING GRANULOCYTE COLONY STIMULATION ACTIVITY, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
US5686268A (en) * | 1992-06-19 | 1997-11-11 | Pfizer Inc. | Fused proteins |
DE4244915C2 (en) * | 1992-08-14 | 1998-12-03 | Widmar Prof Dr Tanner | Fungal cells contg. mutated DPM2 mannosyl transferase gene |
AU5171293A (en) * | 1992-10-14 | 1994-05-09 | Regents Of The University Of Colorado, The | Ion-pairing of drugs for improved efficacy and delivery |
FR2726471B1 (en) * | 1994-11-07 | 1997-01-31 | Pf Medicament | PROCESS FOR IMPROVING THE IMMUNOGENICITY OF AN IMMUNOGENIC COMPOUND OR A HAPTENA AND APPLICATION TO THE PREPARATION OF VACCINES |
AT403167B (en) * | 1994-11-14 | 1997-11-25 | Immuno Ag | SELECTION AND EXPRESSION OF FOREIGN PROTEINS BY MEANS OF A SELECTION-AMPLIFICATION SYSTEM |
US6048964A (en) * | 1995-12-12 | 2000-04-11 | Stryker Corporation | Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
GB9526733D0 (en) * | 1995-12-30 | 1996-02-28 | Delta Biotechnology Ltd | Fusion proteins |
US6605699B1 (en) * | 1997-01-21 | 2003-08-12 | Human Genome Sciences, Inc. | Galectin-11 polypeptides |
US6514500B1 (en) * | 1999-10-15 | 2003-02-04 | Conjuchem, Inc. | Long lasting synthetic glucagon like peptide {GLP-!} |
EP1832599A3 (en) * | 2000-04-12 | 2007-11-21 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US20050054051A1 (en) * | 2001-04-12 | 2005-03-10 | Human Genome Sciences, Inc. | Albumin fusion proteins |
AU2002332041A1 (en) * | 2001-10-05 | 2003-04-22 | Human Genome Sciences, Inc. | Albumin fusion proteins |
-
2002
- 2002-10-04 AU AU2002332041A patent/AU2002332041A1/en not_active Abandoned
- 2002-10-04 WO PCT/US2002/031794 patent/WO2003030821A2/en not_active Application Discontinuation
-
2004
- 2004-04-02 US US10/816,042 patent/US20050037022A1/en not_active Abandoned
-
2006
- 2006-01-30 US US11/341,748 patent/US20060166329A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5216131A (en) * | 1989-02-23 | 1993-06-01 | Genentech, Inc. | Lymphocyte homing receptors |
US6210901B1 (en) * | 1994-01-31 | 2001-04-03 | Roche Diagnostics Gmbh | Specific binding substances for antibodies and their use for immunoassays or vaccines |
US6121231A (en) * | 1996-12-06 | 2000-09-19 | Institut Pasteur | Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuromal and neural injury |
US6548653B1 (en) * | 1998-06-15 | 2003-04-15 | Genzyme Transgenics Corporation | Erythropoietin analog-human serum albumin fusion |
US20010056075A1 (en) * | 1999-07-19 | 2001-12-27 | Jeno Gyuris | Chimeric polypeptides of serum albumin and uses related thereto |
Also Published As
Publication number | Publication date |
---|---|
US20060166329A1 (en) | 2006-07-27 |
US20050037022A1 (en) | 2005-02-17 |
WO2003030821A2 (en) | 2003-04-17 |
AU2002332041A1 (en) | 2003-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003060071A3 (en) | Albumin fusion proteins | |
WO2001079443A3 (en) | Albumin fusion proteins | |
WO2005003296A3 (en) | Albumin fusion proteins | |
WO2005077042A3 (en) | Albumin fusion proteins | |
WO2003030821A3 (en) | Albumin fusion proteins | |
WO2003059934A3 (en) | Albumin fusion proteins | |
WO2007021494A3 (en) | Albumin fusion proteins | |
WO2008033413A3 (en) | Albumin fusion proteins | |
WO2007146038A3 (en) | Albumin fusion proteins | |
WO2002002624A3 (en) | B7-like molecules and uses thereof | |
WO2002024891A3 (en) | B7-like molecules and uses thereof | |
WO2006119987A3 (en) | Recombinant n-glycosylated proteins from procaryotic cells | |
WO2001092308A3 (en) | Cystine-knot polypeptides: cloaked-2 molecules and uses thereof | |
WO2001070977A3 (en) | Fibroblast growth factor receptor-like molecules and uses thereof | |
WO2001061007A3 (en) | Fibroblast growth factor-23 molecules and uses thereof | |
WO2002014485A3 (en) | Kallikrein gene | |
WO2001068854A3 (en) | Fibroblast growth factor-like molecules and uses thereof | |
WO2000053776A3 (en) | Human kallikrein-like genes | |
WO2001042474A3 (en) | Interferon-like molecules and uses thereof | |
WO2002102316A3 (en) | Histone deacetylase and methods of use thereof | |
WO1999001551A3 (en) | Novel inhibitor of cellular proliferation | |
WO2002097046A3 (en) | B7 related protein-2 molecules and uses thereof | |
WO2001059120A3 (en) | Il-17 like molecules and uses thereof | |
WO2002044366A3 (en) | Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 | |
WO2001036478A3 (en) | Methods and compositions relating to bactericidal/permeability increasing factor-like polypeptides and polynucleotides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 10816042 Country of ref document: US |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |